Antitumor effects of ribavirin in combination with TMZ and IFN-β in malignant glioma cells

The prognosis of gioblastoma, the standard chemotherapy agent for which is temozolomide (TMZ), remains poor despite recent advances in multimodal treatments. Therefore, it is necessary to identify and develop novel therapeutics for this malignant disease. Ribavirin, an anti-viral agent which is one...

Descripción completa

Detalles Bibliográficos
Autores principales: Ochiai, Yushi, Sumi, Koichiro, Sano, Emiko, Yoshimura, Sodai, Yamamuro, Shun, Ogino, Akiyoshi, Ueda, Takuya, Suzuki, Yutaka, Nakayama, Tomohiro, Hara, Hiroyuki, Katayama, Yoichi, Yoshino, Atsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475644/
https://www.ncbi.nlm.nih.gov/pubmed/32934745
http://dx.doi.org/10.3892/ol.2020.12039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475644/
https://www.ncbi.nlm.nih.gov/pubmed/32934745
http://dx.doi.org/10.3892/ol.2020.12039

Ejemplares similares